| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/02/2011 | CN101962381A Alkaloid with anticancer activity and preparation method and application thereof |
| 02/02/2011 | CN101962350A Beta-aryl homoallylic amine compound with optical activity, synthesis method and application |
| 02/01/2011 | US7880004 protein tyrosine kinase inhibitors such as 4-(1H-Pyrrolo[2,3-b]pyridin-4-yloxy)-2,5-difluoro-N-(1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridin-3-yl)benzamide, trifluoroacetic acid salt, useful for the treatment of cancer |
| 02/01/2011 | US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879879 Biphenyl derivatives |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879849 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases |
| 02/01/2011 | US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 02/01/2011 | US7879844 Heterocyclic janus kinase 3 inhibitors |
| 02/01/2011 | US7879834 Spiroindoline modulators of muscarinic receptors |
| 02/01/2011 | US7879492 redox system; lithium batteries; nontoxic; improved electroconductivity |
| 02/01/2011 | CA2609634C Tetracyclic azapyrazinoindolines as 5-ht2 ligands |
| 02/01/2011 | CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 02/01/2011 | CA2467097C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 02/01/2011 | CA2446812C Novel sulfonate-substituted pyrazolopyridine derivatives |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2369560C Agent for prophylaxis and treatment of liver disease |
| 02/01/2011 | CA2351707C Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| 01/27/2011 | WO2011011522A2 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/27/2011 | WO2011011494A1 Imidazoazepinone compounds |
| 01/27/2011 | WO2011010840A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011010839A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | WO2010130424A9 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| 01/27/2011 | WO2010104324A3 Halogenated isoindole compounds with superior binding affinity to beta-amyloid aggregates and fibrils, method for preparing same, and use thereof |
| 01/27/2011 | US20110021778 Process for the Preparation of Substantially Pure Palonosetron and its Acid Salts |
| 01/27/2011 | US20110021776 Compositions for the treatment of central nervous system diseases and disorders |
| 01/27/2011 | US20110021772 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 01/27/2011 | US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021556 Pyrrolidinyl derivatives and uses thereof |
| 01/27/2011 | US20110021543 Heterocyclic compounds and their use as pesticides |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021522 Activators of executioner procaspases 3, 6 and 7 |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021516 Monocyclic cgrp receptor antagonists |
| 01/27/2011 | US20110021500 Novel compounds |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021494 Novel tetrahydro-fused pyridines as histone deacetylase inhibitors |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021352 Herbicidal compounds |
| 01/27/2011 | US20110020388 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | CA2768466A1 Hdac inhibitors and therapeutic methods using the same |
| 01/27/2011 | CA2767772A1 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/26/2011 | EP2277881A1 Heterocyclic compound having inhibitory activity on p13k |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2277507A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/26/2011 | EP2276769A1 New peptidomimetic compounds |
| 01/26/2011 | EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders |
| 01/26/2011 | EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/26/2011 | EP2276748A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 01/26/2011 | EP2276744A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof |
| 01/26/2011 | EP2276737A1 4- [3- (aryloxy) benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276486A2 Novel substituted imidazoquinolines |
| 01/26/2011 | EP2125804B1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 01/26/2011 | EP1697377B1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1829521B Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 01/26/2011 | CN1726603B Charge transport compositions and electronic devices made with such compositions |
| 01/26/2011 | CN101959888A Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloal kanes |
| 01/26/2011 | CN101959887A Pyrrolopyridines as kinase inhibitors |
| 01/26/2011 | CN101959886A Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 01/26/2011 | CN101959885A Derivatives of N-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959884A Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959877A Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/26/2011 | CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 01/26/2011 | CN101955480A Pyrazolo [3,4-b] quinoline compound and preparation method thereof |
| 01/26/2011 | CN101250187B Fatty amido substituted methylindole quinoline derivatives as well as preparation method and use thereof as anti-tumour drugs |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | US7875720 Antiscaling agents; the monomer N-allyl-4-(2-N',N'-dimethylaminoethoxy)naphthalimide, methyl sulfate quaternary salt |
| 01/25/2011 | US7875626 Therapeutic agents |
| 01/25/2011 | US7875604 Compounds that inhibit HIV particle formation |
| 01/25/2011 | US7875368 benzoxazole or imidazolopyridine compounds and charge transfer compounds, interposed between a pair of electrodes, to form organic electroluminescent devices, having high emission luminance and efficiency |
| 01/25/2011 | CA2576297C Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 01/25/2011 | CA2506648C 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2443868C 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
| 01/20/2011 | WO2011008915A1 Pyrrolopyridine inhibitors of kinases |
| 01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | WO2011007856A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer |
| 01/20/2011 | WO2011007756A1 Heterocyclic compound and use thereof |
| 01/20/2011 | WO2011007633A1 Crystals of pyrroloquinolinequinone sodium salts |
| 01/20/2011 | WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
| 01/20/2011 | WO2011006638A1 Process for the synthesis of paliperidone |
| 01/20/2011 | WO2011006610A1 Non-polar and polar leaving groups |
| 01/20/2011 | WO2011006567A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 01/20/2011 | WO2010003475A8 Novel pyrrolidone derivatives for use as metap-2 inhibitors |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015198 Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |